When generics turn into Big Pharma

Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims  

Pills by jugaad: Excerpts from Bottle of Lies

A new investigative book, Bottle of Lies, says that Indian cancer drugs are contaminated; cholesterol medication has shards of glass; and, blood …

COVID-19 also brings focus back on pollution due to pharmaceuticals

No time for quick-fix measures. India needs stricter laws  

Colour code for generic medicines a no-brainer

There are a number of systemic gaps without addressing which the government’s latest plan for the pharma sector won’t work

A Patient's Dilemma

Doctors continue to push for branded medications, after the government's launch of an affordable medicine campaign, at the expense of their …

This is why Hepatitis B, Hepatitis C are dangerous

Just one in 10 infected know their status and many are unaware that the inflamation of the liver is a common and treatable disease

Generic drugs needed to eliminate Hepatitis C, say experts

Currently, medicines available to treat patients are exorbitantly priced

Civil society challenges patents on Hepatitis C drugs

Pharmaceutical corporations obtain unjustified patents making the drugs unaffordable to many, petitioners claim  

Government stand against EU ban on Indian drugs much needed, says industry

Standing against the arbitrary ban on 700 drugs, India has decided to defer the proposed talks on the free trade agreement between India and the EU

Ranbaxy effect: Indian government defends pharma industry

Few isolated cases cannot undermine well regulated system, says commerce ministry

COVID-19 underlines medicine interdependency, which is not good: Experts

Countries must come out of global value chain and become self-dependent, they said

Gilead signs agreements with Indian generic companies for hepatitis C drug

Indian companies granted licence to produce generic sofosbuvir and investigational single tablet regimen of ledipasvir/sofosbuvir for treatment …

Six reasons why antibiotics access remains a challenge in Uganda

Lack of registry, sub-standard health facilities, poor cold storage, limited expenditure on health, irrational antibiotic use and lack of …

Highlights of 2016 International AIDS Conference in South Africa

South Africa has the highest infection rate in the world with about seven million affected

Look back at the decade: Generic drugs

Fifteen years after it rose and went limp, the biotech sector saw a bull run of sorts

Predatory EU pacts

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global

Beware of Japan's trade ambitions

Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines

Profits and not improving accessibility matter to Indian drug makers

FICCI conference organised to discuss access to generic medicines focuses more on increasing exports

Pills for polls

The free medicine scheme in Rajasthan may benefit Congress

Activists demand compulsory licence for another life-saving cancer drug

Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs

AAP promises to improve health set-up and promote generic medicines in Delhi

Party says it will address health concerns of both the elderly and the young if it is voted to power

The NATCO CL fallout

The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market

Vidarbha gets its first generic medicines shop

Challenge to popularising these stores is to get doctors to prescribe low-cost generic drugs

EU fines nine pharma companies for violating competition rules

Lundbeck pharma made other companies enter market late with generic versions of its drug citalopram

Getting the drug equation right

Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety